In HIV-infected patients, genetic variations in the CCL2/CCR2 pathway have been associated with survival, and polymorphisms that increase the expression of CCL2 have been repeatedly associated with the presence of subclinical atherosclerosis [30–32]. The gene discussed is CCL2; the disease is atherosclerosis.